These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Author: Parkes JD, Baxter RC, Marsden CD, Rees JE.
    Journal: J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913.
    Abstract:
    Fourteen slightly disabled patients with Parkinsonism were treated separately with benzhexol, amantadine, and levodopa. Benzhexol and amantadine both gave a 15% reduction in functional disability and levodopa a 36% reduction. Benzhexol lessened the rigidity and improved the flexion of posture of Parkinson's disease, but had little or no effect on akinesia and tremor. Amantadine and levodopa caused improvement in all these symptoms. The combination of benzhexol and amantadine was as effective after four weeks of treatment as levodopa was after six months.
    [Abstract] [Full Text] [Related] [New Search]